R.PR
REGISTERED-PRINCIPAL REGISTER
09/11/2021
Voltar para busca
Dado oficial do USPTO
GRABODY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
21/04/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
21/03/2020
Data de registro
09/11/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/11/2021
Última transação
21/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
3
Tipo de titular
03
Localização do titular
Gyeonggi-do, KR
Examinador
ROSEN, BENJAMIN H
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "GRABODY" in which the "Y" is a stylized rendering of an antibody symbol in which the light chain elements of the antibody symbol are of orange color, and in which the heavy chain elements of the antibody symbol as well as the letters "G", "R", "A", "B", "O", and "D" are of black color.
Titulares e representantes
Titulares
ABL Bio, Inc.
Representantes
Steven J. Hultquist HULTQUIST, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
ophthalmic preparations; ophthalmologic preparations; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes for the treatment and prevention of cancersneurodegenerative diseasesinfectious diseases; diagnostic reagents for medical or veterinary purposes; biotechnological pharmaceutical preparations for medical purposes for the treatment and prevention of cancersneurodegenerative diseasesinfectious diseases; biological preparations for medical purposes for the treatment and prevention of cancersneurodegenerative diseasesinfectious diseases; antibodies being biological preparations for medical purposes for the treatment and prevention of cancersneurodegenerative diseasesinfectious diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations acting on the central nervous system; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease; anti-cancer preparations; tumor suppressing agents; immunostimulants; pharmaceutical compositionspharmaceutical preparations for the treatment and prevention of cancersneurodegenerative diseasesinfectious diseases
Classe 42
scientific research in the fields of biomedicine; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of technology for biotechnology; biotechnological research; medical research in the field of medicine; scientific research in the field of medicine; laboratory research services relating to pharmaceuticals; scientific research in the field of medicinal products; research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; pharmaceutical research and development; research on the subject of pharmaceuticals; medical and scientific researchconducting testing in the nature of clinical trials of medicines for others; medical and scientific researchconducting studies in the nature of clinical trials of medicines for others; development of cell therapy products; scientific research in the field of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/08/2021
PUBO
PUBLISHED FOR OPPOSITION
24/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/08/2021
OTHE
CASE RETURNED TO EXAMINATION
20/07/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
20/07/2021
APET
ASSIGNED TO PETITION STAFF
12/07/2021
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
25/06/2021
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
24/06/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/03/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
24/01/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
15/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/09/2020
PUBO
PUBLISHED FOR OPPOSITION
15/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/08/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/08/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/04/2020
GNRT
NON-FINAL ACTION E-MAILED
21/04/2020
CNRT
NON-FINAL ACTION WRITTEN
21/04/2020
DOCK
ASSIGNED TO EXAMINER
21/04/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
26/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/03/2020
NWAP
NEW APPLICATION ENTERED
25/03/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GRABODY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.